Ophthalmology And Visual Sciences

Stephen R. Russell, MD

Portrait

Dina J Schrage Professor of Macular Degeneration Research
Service Director, Vitreoretinal Diseases and Surgery
Professor of Ophthalmology and Visual Sciences

Contact Information

Primary Office: 11196I  PFP
Iowa City, IA 52242
Primary Office Phone: 319-356-4588

Email: steve-russell@uiowa.edu

Education

BS, Electrical Engineering and Biology , Stanford University
MD, UCLA School of Medicine

Internship, Harbor - UCLA School of Medicine
Residency, Ophthalmology, Bascom Palmer Eye Institute
Fellowship, Vitreoretinal Diseases and Surgery, University of Iowa

Licensure and Certifications

California Medical License, Medical Board of California
ABO Certification, American Board of Ophthalmology
National Boards III
National Boards II
NBME Diplomate, National Board of Medical Examiners
National Boards I

Center, Program and Institute Affiliations

Carver Family Center for Macular Degeneration
Stephen A. Wynn Institute for Vision Research

All Publications

Chen J, Sohn E, Folk J, Mahajan V, Kay C, Boldt H, Russell S.  Decreased macular thickness in nonproliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.  Retina;  2014. 

Zhang L, Sonka M, Russell S, Folk J, Abramoff M.  Quantifying disrupted outer retina-subretinal layer in SD-OCT images in choroidal neovascularization.  Invest Ophthalmol Vis Sci.  2014. 55(4):2329-35.
[PubMed]

Almeida D, Chin E, Russell S.  Spontaneous resolution of vitreomacular traction in two patients with diabetic macular edema.  Case Reports in Ophthalmology.  2014. 5(1):66-71.

 .  Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study.  Ophthalmology.  2013 November 8. 

 .  Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.  Ophthalmology.  2013 September. 120(9):1871-9.

 .  Macular Morphology and Viscual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials.  Ophthalmology.  2013 September. 120(9):1860-70.

Steinberg J, Auge J, Jaffe G, Fleckenstein M, Holz F, Schmitz-Valckenberg S,  .  Longitudinal Analysis of Reticular Drusen Associated with Geogrpahic Atrophy in Age-Related Macular Degeneration.  Invest Ophthalmol Vis Sci.  2013 June 10. 54(6):454-60.

Cunningham M, Tlucek P, Folk J, Boldt H, Russell S.  Acute, non-infectious uveitis subsequent to both intravitreal bevacizumab and ranibizumab injections.  Retinal Cases and Brief Reports.  2013 June. 

 .  Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-Related Macular Degeneration Treatments Trials.  Ophthalmology.  2013 May 22. 

Bakall B, Folk J, Boldt H, Sohn E, Stone E, Russell S, Mahajan V.  Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab..  Am J Ophthalmol.  2013 May. 156(1):15-22.
[Link]

Scheetz T, Fingert J, Wang K, Kuehn M, Knudtson L, Alward W, Boldt H, Russell S, Folk J, Casavant T, Braun T, Clark A, Stone E, Sheffield V.  A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci..  PLoS One;  2013.  Available from: http://www.ncbi.nlm.nih.gov/pubmed/23536807

Tozer K, Roller A, Chong L, Sadda S, Folk J, Mahajan V, Russell S, Boldt H, Sohn E.  Combination Therapy for Neovascular Age-Related Macular Degeneration Refractory to Anti-Vascular Endothelial Growth Factor Agents..  Ophthalmology;  2013.  Available from: http://www.ncbi.nlm.nih.gov/pubmed/23714319

Abramoff M, Folk J, Han D, Walker J, Williams D, Russell S, Massin P, Cochener B, Gain P, Tang L, Lamard M, Moga D, Quellec G, Niemeijer M.  Automated analysis of retinal images for detection of referable diabetic retinopathy.  JAMA Ophthalmol.  2013 March 1. 131(3):351-7.
[Link]

Bakall B, Folk J, Boldt H, Sohn E, Stone E, Russell S, Mahajan V.  Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab.  Am J Ophthalmol.  2013. 

Niemeijer M, van Ginneken B, Russell S, Suttorp-Schulten M, Abramoff M.  Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color funds photographs for diabetic retinopathy diagnosis [reprint].  ARVO.  2013. 

Russell S, Boldt H, Folk J, Sohn E, Tarantola R, Kay C, Mahajan V.  Elimination of Infusion Bubbles and Uncontrolled Reflux in the Alcon Constellation Vitrectomy vision System.  Retina.  2013. 33(4):803-6.
[PubMed]

Chew E, Clemons T, Agron E, Sperduto R, Sangiovanni J, Kurinij N, Davis M,  , Folk J, Russell S.  Long-Term Effects of Vitamins C and E, beta-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35.  Ophthalmology.  2013. 120(8):1604-1611.
[PubMed]

 .  Pharmacogenetics for Genes Associated with Age-realted Macular Degeneration in the Comparison of AMD Treatments Trials (CATT).  Ophthalmology.  2013. 120(3):593-599.

Cunningham M, Tarantola R, Folk J, Sohn E, Boldt H, Graff J, Elkins K, Russell S, Mahajan V.  Proliferative vitreoretinopathy may be a risk facotr in combined macular hole retinal detachment cases.  Retina.  2013. 33(3):579-85.
[PubMed]

Cunningham M, Tlucek P, Folk J, Boldt H, Russell S.  Sequential, Acute Noninfectious Uveitis Associated with Separate Intravitreal Injections of Bevacizumab and Ranibizumab.  Retinal Cases & Brief Reports.  2013. 7(4):1.

Russell S, Dvorak L.  The Lost Art of Retinal Drawing.  Iowa Retinal Publishers;  2013.

van Dijk H, Verbraak F, Kok P, Oberstein S, Schlingemann R, Russell S, Abramoff M.  Variability in photocoagulation treatment of diabetic macular oedema.  Acta Ophthalmol.  2013. 91(8):722-7.
[Link]

 .  Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.  Ophthalmology.  2013 January. 120(1):122-9.

Tarantola R, Tsui J, Graff J, Russell S, Boldt H, Mahajan V, Folk J.  Intraoperative sclerotomy-related retinal breaks during 23-gauge pars plana vitrectomy.  Retina.  2013 January. 33(1):136-142.
[PubMed]

Cunningham M, Tarantola R, Folk J, Sohn E, Boldt H, Graff J, Russell S, Mahajan V.  Proliferative Vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases.  Retina.  2012 December 7. 
[Link]

Russell S, Sohn E, Boldt H, Folk J, Tarantola R, Kay C, Mahajan V.  Elimination of Infusion Bubbles and Uncontrolled Reflux in the ALCON Constellation Vitrectomy Vision System.  Retina.  2012 December 5. 
[PubMed]

Skeie J, Brown E, Martinez H, Russell S, Birkholz E, Folk J, Boldt H, Gehrs K, Stone E, Wright M, Mahajan V.  Proteomic analysis of vitreous biopsy techniques..  Retina.  2012 November. 32(10):2141-2149.
[Link]

Christopher M, Moga D, Russell S, Folk J, Scheetz T, Abramoff M.  Validation of tablet-based evaluation of color fundus images..  Retina.  2012 September. 32(8):1629-1635.
[Link]

Johnson M, Brucker A, Chang S, Gandorfer A, Kampik A, Kuppermann B, Russell S, Spaide R, Thompson J.  Vitreomacular disorders: pathogenesis and treatment..  Retina.  2012 September. 32(Suppl 2):S173.
[Link]

Russell S.  What we know (and do not know) about vitreoretinal adhesion..  Retina.  2012 September. 32(Suppl 2):S181-186.
[Link]

Davis A, Folk J, Russell S, Sohn E, Boldt H, Stone E, Mahajan V.  Intravitreal bevacizumab for peripapillary choroidal neovascular membranes..  Arch Ophthalmol.  2012 August 1. 130(8):1073-1075.
[Link]

Tarantola R, Tsui J, Graff J, Russell S, Boldt H, Mahajan V.  INTRAOPERATIVE SCLEROTOMY-RELATED RETINAL BREAKS DURING 23-GAUGE PARS PLANA VITRECTOMY..  Retina.  2012 July 11. 
[Link]

 .  Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: Two-Year Results.  Ophthalmology (E-Pub 2012 May 1).  2012 July. 119(7):1388-98.

 .  Use of the Michigan Neuropathy Screening Instrument (MNSI) as a Measure of Distal Symmetrical Peripheral Neuropathy (DSPN) in Type 1 Diabetes.  Diabet Med.  2012 July. 29(7):937-944.

Schweitzer D, Gaillard E, Dillon J, Mullins R, Russell S, Hoffman B, Peters S, Hammer M, Biskup C.  Time-Resolved Autofluorescence Imaging of Human Donor Retina Tissue from Donors with Significant Extramacular Drusen.  Invest Ophthalmol Vis Sci.  2012 June 10. 53(7):3376-3386.
[PubMed]

Tozer K, Roller A, Chong L, Sadda S, Folk J, Mahajan V, Russell S, Boldt H, Sohn E.  Addition of Photodynamic Therapy for the Treatment of Neovacular AMD Refractory to Anti-VEGF Agents.  Ophthalmology.  2012. 

Abràmoff M, Folk J, Han D, Walker J, Williams D, Russell S, Massin P, Cochener B, Gain P, Tang L, Lamard M, Moga D, Quellec G, Niemeijer M.  Automated Analysis of Retinal Images compared to Readings by Retinal Specialists in Detecting the Need for Referral for Diabetic Retinopathy.  JAMA.  2012. 

Cideciyan A, Swider M, Aleman T, Feuer W, Schwartz S, Russell R, Steinberg J, Stone E, Jacobson S.  Macular Function in Macular Degenerations: Repeatability of Microperimetry as a Potential Outcome Measure for ABCA4-Associated Retinopathy Trials.  Invest Ophthalmol Vis Sci.  2012. 53(2):841-52.
[PubMed]

 .  Optical Coherence Tomogrpahy Grading Reproducibility during the Comparison of Age-Related Macular Degeneration Treatment Trials.  Ophthalmology.  2012. 119(12):2549-22557.

 .  Photographic Assessment of Baseline Fundus Morphologic Features in the Comparison of Age-related Macular Degeneration Treatments Trials.  Ophthalmology.  2012. 119:1634-1641.

 .  ProVision: Ophthalmic Multiple-Choice Questions with Discussions.  5 (print and online). American Academy of Ophthalmology;  2012.

 .  Study Design and Baseline Characteristics (AREDS2 Report Number 1).  Ophthalmology.  2012. 119:2282-2289.

Quellec G, Russell S, Seddon J, Reynolds R, Scheetz T, Mahajan V, Stone E, Abramoff M.  Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration.  Invest Ophthalmol Vis Sci.  2011 November 25. 52(12):9195-9206.
[Link]

Roller A, Folk J, Patel N, Boldt H, Russell S, Abramoff M, Mahajan V.  Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.  Retina.  2011 October. 31(9):1848-1855.
[Link]

Davis L, Meyer K, Schindler E, Beck J, Rudd D, Grundstad A, Scheetz T, Braun T, Fingert J, Alward W, Kwon Y, Folk J, Russell S, Wassink T, Sheffield V, Stone E.  Copy number variations and primary open-angle glaucoma.  Invest Ophthalmol Vis Sci.  2011 September 9. 52(10):7122-7133.
[Link]

Schmitz-Valckenberg S, Alten F, Steinberg J, Jaffe G, Fleckenstein M, Mukesh B, Hohman T, Holz F,  .  Reticular drusen associated with geographic atrophy in age-related macular degeneration.  Invest Ophthalmol Vis Sci.  2011 August 24. 52(9):5009-15.
[Link]

Schmitz-Valckenberg S, Alten F, Steinberg J, Jaffe G, Fleckenstein M, Mukesh B, Hohman T, Holz F, Russell S, Geographic Atrophy Progression (GAP) Study Group .  Reticular drusen associated with geographic atrophy in age-related macular degeneration.  Invest Ophthalmol Vis Sci.  2011 August 24. 52(9):5009-5015.
[Link]

Russell S, Dvorak L.  Retinal drawing: a lost art of medicine..  Perm J.  2011 July. 15(3):74-75.
[Link]

Kay C, Tarantola R, Gehrs K, Folk J, Mahajan V, Boldt H, Syed N, Russell S.  Uveitis following intravitreal bevacizumab: a non-infectious cluster.  Ophthalmic Surg Lasers Imaging.  2011 July. 42(4):292-296.
[Link]

 .  Subject Characteristics and Study Features Associated with High Retention Rates in a Longitudinal Investigation of Type 1 Diabetes Mellitus.  Clinical Trials.  2011 June 17. 

 .  The Long-Term Effects of Type 1 Diabetes Treatment And Complications On Health-Related Quality-Of-Life: A 21 Year Follow-Up Of The Diabetes Control And Complications Trial/Epidemiology Of Diabetes Interventions And Complications Cohort.  Journal of the American Medical Association.  2011 June 15. 

 .  Myocardial Structure, Function and Scar in Patients with Type 1 Diabetes.  Circulation.  2011 May 31. 

Roller A, Folk J, Patel N, Boldt H, Russell S, Abramoff M, Mahajan V.  Intravitreal Bevacizumab for Treatment of Proliferative and Nonproliferative Type 2 Idiopathic Macular Telangiectasia.  Retina .  2011 May 21. 31(9):1848-55.
[PubMed]

Dvorak L, Russell S.  Retinal Drawing: A Lost Art of Medicine.  The Permanente Journal.  2011 Summer. 15(3):74-75.
[PubMed]

Quellec G, Russell S, Scheetz T, Stone E, Abramoff M.  Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt's disease.  Invest Ophthalmol Vis Sci.  2011 May 6. 52(6):2976-2981.
[Link]

Tarantola R, Folk J, Shah S, Boldt H, Abramoff M, Russell S, Mahajan V.  Intraoperative choroidal detachment during 23-gauge vitrectomy.  Retina.  2011 May. 31(5):893-901.
[Link]

Mahajan V, Tarantola R, Graff J, Boldt H, Abramoff M, Russell S, Folk J.  Sutureless triplanar sclerotomy for 23-gauge vitrectomy.  Arch Ophthalmol.  2011 May. 129(5):585-90.
[Link]

Murakami K, Koide M, Dumont T, Russell S, Tranmer B, Wellman G.  Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein.  Transl Stroke Res.  2011 March 1. 2(1):72-79.

Quellec G, Russell S, Abramoff M.  Optimal filter framework for automated, instantaneous detection of lesions in retinal images.  IEEE Trans Med Imaging.  2011 February. 30(2):523-33.
[Link]

Schmitz-Valckenberg S, Fleckenstein M, Göbel A, Hohman T, Holz F,  .  Optical coherence tomography and autofluorescence findings in areas with geographicatrophy due to age-related macular degeneration.  Invest Ophthalmol Vis Sci.  2011 January 5. 52(1):1-6.
[PubMed]

 .  Biomedical Risk Factors for Decreased Cognitive Functioning in Type 1 Diabetes: An 18 Year Follow-Up of the DCCT Cohort.  Diabetologia.  2011. 54:245-255.

 .  Comparison of Digital and Film Grading of Diabetic Retinopathy Severity in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.  Arch Ophthalmol.  2011. 129(6):718-726.

 .  Determining Stability of Stored Samples Retrospectively: The Validity of Glycated Albumin.  Clinical Chemistry.  2011. 57:286-290.

 .  Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes.  Journal of Urology.  2011. 185:1828-1834.

 .  Gaps in the Glycation Gap Hypothesis.  Clin Chemistry.  2011. 57:150-152.

 .  Levels of Oxidized LDL and Advanced Glycation End Products-Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes.  Diabetes.  2011. 60(2):582-589.

 .  Long-term Renal Outcomes of Patients with Type 1 Diabetes and Microalbuminuria: An Analysis of the DCCT/EDIC Cohort.  Archives of Internal Medicine.  2011. 171:412-420.

 .  Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.  Diabetes.  2011. 60(2):607-613.

 .  Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration.  N Engl J Med.  2011. 10:1056.

Jacobson S, Cideciyan A, Gibbs D, Sumaroka A, Roman A, Aleman T, Schwartz S, Olivares M, Russell R, Steinberg J, Kenna M, Kimberling W, Rehm H, Williams D.  Retinal Disease Course in Usher Syndrome 1B due to MYO7A Mutations.  Invest Ophthalmol Vis Sci.  2011. 52(11):7924-36.
[PubMed]

 .  T(1) Mapping of the Gadolinium-Enhanced Myocardium: Adjustment for Factors Affecting Interpatient Comparison.  Magnetic Resonance in Medicine.  2011. 65:1407-1415.

Mahajan V, Elkins K, Russell S, Boldt H, Gehrs K, Weingeist T, Stone E, Abramoff M, Liu D, Folk J.  Bilateral intravitreal injection of antivascular endothelial growth factor therapy.  Retina.  2011 January. 31(1):31-35.
[Link]

Meyer K, Davis L, Schindler E, Beck J, Rudd D, Grundstad A, Scheetz T, Braun T, Fingert J, Alward W, Kwon Y, Folk J, Russell S, Wassink T, Stone E, Sheffield V.  Genome-wide analysis of copy number variants in age-related macular degeneration.  Hum Genet.  2011 January. 129(1):91-100.
[Link]

Skeie J, Fingert J, Russell S, Stone E, Mullins R.  Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells.  Invest Ophthalmol Vis Sci.  2010 October. 51(10):5336-5342.
[Link]

Roller A, Mahajan V, Boldt H, Abramoff M, Russell S, Folk J.  Effects of vitrectomy on age-related macular degeneration.  Ophthalmology.  2010 July. 117(7):1381-6.
[Link]

Abràmoff M, Reinhardt J, Russell S, Folk J, Mahajan V, Niemeijer M, Quellec G.  Automated early detection of diabetic retinopathy.  Ophthalmology.  2010 June. 117(6):1147-54.
[Link]

Abramoff M, Niemeijer M, Russell S.  Automated detection of diabetic retinopathy: barriers to translation into clinical practice.  Expert Rev Med Devices.  2010 March. 7(2):287-96.
[Link]

Rauen M, Russell S, Tauber S, Goins K.  Surgical management of a posterior dislocated intraocular lens after descemet stripping automated endothelial keratoplasty.  Cornea.  2010 March. 29(3):350-3.
[Link]

 .  Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.  Clin J Am Soc Nephrol.  2010. 5(7):1235-1242.

 .  DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history.  Curr Diab Rep.  2010. 10(4):276-282.

 .  Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.  Diabetes Care.  2010. 33(7):1536-1543.

 .  Disparity in the management of Coronary Heart Disease (CHD) Risk Factors by Sex in DCCT/EDIC.  Diabet Med.  2010. 27(4):451-458.

 .  Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the DCCT.  American Journal of Kidney Diseases.  2010. 55:824-834.

 .  Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.  Diabetes Care.  2010. 33(5):1090-1096.

 .  Effect of prior intensive therapy in type 1 Diabetes on 10-Year Progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.  Diabetes.  2010. 59(5):1244-1253.

Agurto C, Murray V, Barriga E, Murrillo S, Pattichis M, Davis H, Russell S, Abramoff M, Soliz P.  Multiscale AM-FM Methods for Diabetic Retinopathy Lesion Detection.  IEEE Transactions on Medical Imaging.  2010. 29(2):502-512.
[PubMed]

Quellec G, Russell S, Abramoff M.  Optimal Filter Framework for Automated, Instantaneous Detection of LEsions in Retinal Images.  IEEE Transactions on Medical Imaging.  2010. 

 .  The Associations of Apolipoprotein E and Angiotensin Converting Enzyme Polymorphisms and Cognitive Function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort.  Diabet Med.  2010. 27(1):15-22.

Quellec G, Abramoff M, Russell S.  Use of a twin dataset to identify AMD-related visual patterns controlled by genetic factors.  Proceedings of the SPIE -The International Society for Optical Engineering (Progress in Biomedical Optics and Imaging Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging).  2010. 7624:76240K.

 .  Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes.  Diabetes Care.  2010. 33:2635-2641.

Maguire M, Ying G, McCannel C, Liu C, Dai Y, Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group .  Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.  Ophthalmology.  2009 December. 116(12):2381-5.
[PubMed]

Mahajan V, Russell S, Stone E.  A new macular dystrophy with anomalous vascular development, pigment spots, cystic spaces, and neovascularization.  Arch Ophthalmol.  2009 November. 127(11):1449-1457.
[Link]

Garvin M, Abràmoff M, Wu X, Russell S, Burns T, Sonka M.  Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images.  IEEE Trans Med Imaging.  2009 September. 28(9):1436-47.
[Link]

Ying G, Maguire M, Alexander J, Martin R, Antoszyk A, Complications of Age-related Macular Degeneration Prevention Trial  .  Complications of Age-related Macular Degeneration Prevention Trial Research Group. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.  Arch Ophthalmol.  2009 September. 127(9):1147-51.
[PubMed]

Garvin M, Abramoff M, Xiaodong W, Russell S, Burns T, Sonka M.  Automated 3-D Intraretinal Layer Segmentation of Macular Spectral-Domain Optical Coherence Tomography Images.  IEEE Trans Med Imaging.  2009. 

Scoles D, Gray D, Wolfe R, Gee B, Geng Y, Masella B, Hunter J, Libby R, Russell S, Williams D, Merigan W.  In-vivo imaging of retinal nerve fiber layer vasculature: imaging-histology comparison.  BMC Ophthalmol.  2009. 23(9):9.

Ying G, Maguire M, Liu C, Antoszyk A, Complications of Age-Related Macular Degeneration Prevention Trial Research Group  .  Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.  Ophthalmology (Epub 2008 Jul 31).  2008 November. 115(11):1876-82.
[PubMed]

Garvin M, Abramoff M, Kardon R, Russell S, Wu X, Sonka M.  Intraretinal layer segmentation of macular optical coherence tomography images using optimal 3-D graph search.  IEEE Trans Med Imaging.  2008 October. 27(10):1495-505.
[Link]

Maguire M, Alexander J, Fine S,  .  Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.  Ophthalmology (Epub 2008 May 16).  2008 September. 115(9):1468-73, 1473.e1-2.
[PubMed]

 .  Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.  Ophthalmology (Epub 2008 May 27).  2008 September. 115(9):1474-9, 1479. e1-6.
[PubMed]

Abràmoff M, Niemeijer M, Suttorp-Schulten M, Viergever M, Russell S, van Ginneken B.  Evaluation of a system for automatic detection of diabetic retinopathy from color fundus photographs in a large population of patients with diabetes.  Diabetes Care.  2008 February. 31(2):193-8.
[Link]

Acton S, Soliz P, Russell S, Pattichis M.  Content based image retrieval: the foundation for future case-based and evidence-based ophthalmology.  IEEE International Conference on Multimedia and Expo.  2008. 

Soliz P, Russell S, Abramoff M, Murillo S, Pattichis M, Davis H.  Independent component analysis for vision-inspired classification of retinal images with age-related macular degeneration.  IEEE Southwest Symposium on Image Analysis and Interpretation.  2008. 

Garvin M, Abramoff M, Kardon R, Russell S, Xiadong W, Sonka M.  Intraretinal Layer Segmentation of Macular Optical Coherence Tomography Images Using Optimal 3-D Graph Search.  IEEE Transactions on Medical Imaging.  2008. 

Niemeijer M, van Ginneken B, Russell S, Suttorp-Schulten M, Abràmoff M.  Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis.  Invest Ophthalmol Vis Sci.  2007 May. 48(5):2260-7.
[Link]

Davis B, Russell S, Abramoff M, Nemeth S, Barriga E, Soliz P.  Identification of spectral phenotypes in age-related macular degeneration patients.  Ophthalmic Technologies XVII.  2007 March 5. 6426:64261.

Steffensmeier A, Azar A, Fuller J, Muller B, Russell S.  Vitreous injections of pegaptanib sodium triggering allergic reactions.  Am J Ophthalmol.  2007 March. 143(3):512-3.
[Link]

Russell S, Hudson H, Jerdan J,  .  Anecortave acetate for the treatment of exudative age-related macular degeneration – a review of clinical outcomes.  Surv Ophthalmol.  2007. 52:S79-S90.

Kaiser P, Goldberg M, Davis A,  .  Posterior juxtascleral depot administration of anecortave acetate.  Surv Ophthalmol.  2007. 52(S1):S62-S69.

Russell S, et al .  Section 8: Retina/Vitreous.  American Academy of Ophthalmology.  2007. 

Russell S, Hudson H, Jerdan J,  .  Anecortave acetate for the treatment of exudative age-related macular degeneration — a review of clinical outcomes.  Surv Ophthalmol.  2007 January. 52(Suppl 1):S79-90.
[PubMed]

Russell S, Hudson H, Jerdan J.  Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.  Surv Ophthalmol.  2007 January. 52 Suppl 1:S79-90.
[Link]

 .  Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.  Ophthalmology.  2006 November. 113(11):1974-86.
[PubMed]

Barriga E, Russell S, Abramoff M, Brittain R, Waymire R, Edwards A, Engstrom R, Davis B, Soliz P.  A training system for photodynamic therapy using modeling and simulation.  19th IEEE International Symposium on Computer-Based Medical Systems. CBMS.  2006. 206:646-652.

Slakter J, Bochow T, D' Amico D, Marks B, Jerdan J, Sullivan E, Robertson S, Slakter J, Sullins G, Zilliox P,  .  Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.  Ophthalmology.  2006. 113(1):3-13.

Yi C, Pan X, Russell S, Agarwal A, Sternberg, JR P.  Diagnostic and Therapeutic Challenges.  Retina.  2006. 26:688-692.

 .  Laser treatment in patients with bilateral large drusen: The Complications of Age-Related Macular Degeneration Prevention Trial.  Ophthalmology.  2006. 113:1874-1986.

Allen R, Russell S, Streb L, Alsheikheh A, Stone E.  Phenotypic heterogeneity associated with a anovel mutation (Gly112Glu) in the Norrie disease protein.  Eye.  2006. 20:234-241.

Allen R, Russell S, Schulter M, Oetting T.  Retained posterior segment indocyanine green dye after phacoemulsification.  J Cataract Refract Surg.  2006. 32:357-360.

Gold B, Merriam J, Zernant J, Hancox L, Taliber A, Gehrs K, Cramer K, Neel J, Bergeron J, Barile G, Smith R,  .  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.  Nature Genetics.  2006. 38(4):458-462.

Gold B, Merriam J, Zernant J, Hancox L, Taiber A, Gehrs K, Cramer K, Neel J, Bergeron J, Barile G, Smith R,  , Hageman G, Dean M, Allikmets R.  Variation in the factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.  Nat Genet.  2006. 38:458-462.

Hageman G, Anderson D, Johnson L, Hancox L, Taiber A, Hardisty L, Hageman J, Stockman H, Borchardt J, Gehrs K, Smith R, Silvestri G, Russell S, Klaver C, Barbazetto I, Chang S, Yannuzzi L, Barile G, Merriam J, Smith R, Olsh A, Bergeron J, Zernant J, Merriam J, Gold B, Dean M, Allikmets R.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.  Proc Natl Acad Sci U S A.  2005 May 17. 102(20):7227-32.
[Link]

Kwon Y, Rickman D, Baruah S, Zimmerman M, Kim C, Boldt H, Russell S, Hayreh S.  Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate.  Eye (Lond).  2005 April. 19(4):455-63.
[Link]

Hoyng C, Vingerling J, Hooymans J, Klamerus K, Younis H, Khalil D, Scassellati-Sforzolini B, Russell S, Schlingemann R.  AG-013958 (VEGFR inhibitor) achieves effective choroidal concentrations with minimal systemic effects in cynomolgus monkeys and humans with age-related macular disease.  Association for Research in Vision and Ophthalmology .  2005. 

Benche I, Madden S, Nemeth S, Russell S, Verdugo-Gadzik M, Wolf S, Soliz P.  Assessment of fill-rate statistics to automatically segment and classify choroidal neovascular lesions in age-related macular degeneration.  Association for Research in Vision and Ophthalmology.  2005. 

Chapper J, Mullins R, Russell S, Guymon C.  Characterization of nano-structured polymers for fabricating and ocular microvascular stent.  Characterization of nano-structured polymers for fabricating and ocular microvascular stent for 2005 annual meeting.  2005. 

Patel C, Stone E, Duffel P, Russell S.  Clinically detectable drusen substructure in fibulin 5 associated age-related macular degeneration.  Association for Research in Vision and Ophthalmology.  2005. 

Barriga E, Zamora G, Russell S, Soliz P.  Detection of spectral variations using independent component analysis of hyperspectral images in patients with age-related macular degeneration.  Association for Research in Vision and Ophthalmology.  2005. 

Bochow T, Harper III C, Marks B, Trost E, Sullivan E,  .  Reflux of study medication affects the clinical outcomes of anecortave acetate for depot suspension in the treatment of patients with exudative age-related macular degeneration (AMD).  Association for Research in Vision and Ophthalmology.  2005. 

Yang S, Barriga S, Erry G, Raman B, Russell S, Mitra S, Soliz P.  Retinal image deconvolution: revealing hidden structures and pathology.  Association for Research in Vision and Ophthalmology .  2005. 

Raman B, Russell S, Verdugo-Gazdik M, Nemeth S, Wolf S, Soliz P, Butler E.  The effect of fundus image quality on detecting clinically significant features in fundus imaging.  Association for Research in Vision and Ophthalmology.  2005. 

Maguire M,  .  Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).  Ophthalmology.  2004 July. 111(7):1307-16.
[PubMed]

Russell S, Gupta R, Folk J, Mullins R, Hageman G.  Comparison of color to fluorescein angiographic images from patients with early-adult onset grouped drusen suggests drusen substructure.  Am J Ophthalmol.  2004 May. 137(5):924-30.
[Link]

Franklin A, Setton T, Kuchemann C, Russell S, Kohn E.  CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.  Invest Ophthalmol Vis Sci.  2004. 45:3756-3766.

Fu A, Brod R, Russell S, Bowie E, Park D, Polk T.  Diagnostic and Therapeutic Challenges.  Retina.  2004. 24:790-795.

Stone E, Braun T, Russell S, Kuehn M, Lotery A, Moore P, Eastman C, Casavant T, Sheffield V.  Missense variations in the fibulin 5 gene are associated with a specific phenotype of age related macular degeneration.  New Enlg J Med.  2004. 351:346-356.

 .  The complications of age-related macular degeneration prevention trial (CAPT): rationale, design and methodology.  Clinical Trials.  2004. 1:91-107.

Honkanen R, Baruah S, Zimmerman M, Khanna C, Weaver Y, Narkiewicz J, Waziri R, Gehrs K, Weingeist T, Boldt H, Folk J, Russell S, Kwon Y.  Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy.  Arch Ophthalmol.  2003 February. 121(2):183-8.
[Link]

Lotery A, Yang G, Mullins R, Russell S, Schmidt M, Stone E, Lindbloom J, Chiorini J, Kotin R, Davidson B.  Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina.  Hum Gene Ther.  2003. 14:1663-1671.

 .  Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): Interim (month 6) analysis of clinical safety and efficacy.  Retina.  2003. 23:14-23.

 .  Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): Interim (month 6) analysis of clinical safety and efficacy.  Retina.  2003. 23:14-23.

D'Amico D, Goldberg M, Hudson H, Jerdan J, Krueger D, Luna S, Robertson S, Russell S, Singerman L, Slakter J, Yannuzzi L, Zilliox P,  .  Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.  Ophthalmology.  2003. 110:2372-2385.

D'Amico D, Goldberg M, Hudson H, Jerdan J, Krueger D, Luna S, Robertson S, Russell S, Singerman L, Slakter J, Yannuzzi L, Zilliox P, The Anecortave Acetate Clinical Study Group .  Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.  Ophthalmology.  2003. 110:2372-2385.

Kitchens J, Lotery A, Russell S, Clark A, Stone E.  Anecortave acetate monotherapy for the treatment of occult and minimally classic choroidal neovascularization in age-related macular degeneration.  Invest Ophthalmol Vis Sci 2003 meeting program.  2003. 2:5093.

 .  Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial.  Ophthalmology.  2003. 110:971-978.

Prenner J, Rosenblatt B, Tolentino M, Ying G, Javornik N, Maguire M, Ho A,  .  Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT.  Retina.  2003. 23:307-314.

 .  Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial.  J Pediatr.  2002. 139:804-812.

Lotery A, Derksen T, Russell S, Mullins R, Sauter S, Affatigato L, Stone E, Davidson B.  Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors.  Hum Gene Ther.  2002. 13:689-696.

Hess C, Russell S.  Optics of Contact Lens (case 2).  2002. 

Russell S, Hageman G.  Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous.  Arch Ophthalmol.  2001 November. 119(11):1653-8.
[Link]

Russell S, Lotery A, Derksen T, Davidson B, Stone E.  A manual, remotely actuated injector for subretinal gene therapy in non-human primates.  Invest Ophthalmol Vis Sci.  2001. 42(4):S126.

Allen R, Kherani A, Russell S, Kwon Y, Oetting T.  Cryptophacolytic glaucoma in two patients with ectopia lentis et pupillae.  MEJO.  2001. 9:81-82.

Lotery A, Derksen T, Mullins R, Kopp K, Rosenow J, Stone E, Davidson B, Sauter S, Russell S.  Evaluation of lentiviral vectors as possible agents for gene therapy to the neurosensory retina in a non-human primate model.  Invest Ophthalmol Vis Sci.  2001. 42(4):S345.

Russell S.  Incontinentia pigmenti (Bloch-Sulzberger Syndrome).  Lippincott Williams & Wilkins.  2001. 

Oh K, Christmas N, Russell S.  Late recurrence and choroidal neovascular¬ization in multiple evanescent white dot syndrome.  Retina.  2001. 21:182-184.

Russell S.  Low vision evaluation.  2001. 

Russell S.  Optics and Lens (case 1).  2001. 

Singerman L, Yannuzzi L, Russell S, Hudson H, Jerdan J,  .  Sub-tenon’s retrobulbar anecortave acetate with and without Visudyne photodynamic therapy (PDT) in patients with subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD).  Invest Ophthalmol Vis Sci.  2001. 42(4):S231.

Kwon Y, Rickman D, Baruah S, Waziri R, Kim C, Zimmerman M, Russell S, Hayreh S.  Vitreous amino acid levels in experimental central retinal artery occlusion in primates.  Invest Ophthalmol Vis Sci.  2001. 42(4):S745.

Honkanen R, Weaver Y, Baruah S, ZImmerman M, Gehrs K, Boldt H, Weingeist T, Russell S, Folk J, Kwon Y.  Vitreous amino acid levels in patients with glaucoma undergoing vitrectomy.  Invest Ophthalmol Vis Sci.  2001. 42(4):S314.

Mullins R, Russell S, Anderson D, Hageman G.  Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.  FASEB J.  2000 May. 14(7):835-46.
[Link]

Russell S, Mullins R, Schneider B, Hageman G.  Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration.  Am J Ophthalmol.  2000 February. 129(2):205-14.
[Link]

Russell S, Gupta R, Folk J, Mullins R, Hageman G.  Comparison of color drusen images to fluorescein angiographic hyperfluorescent lesions in early adult onset (basal laminar) drusen.  Invest Ophthalmol Vis Sci.  2000. 41(4):S169.

Russell S, Weingeist T.  Diagnostic and therapeutic challenges [case report].  Retina.  2000. 20:295-296.

Russell S, Gehrs K, Hess C.  Estimate and measure of the region of view and myopia resulting from vitreous gas.  Retina.  2000. 20(3):282-8.
[Link]

Allen R, Russell S, Andorf J, Stone E.  Phenotypic heterogeneity associated with a novel mutation (Gly112Glu) in the Norrie disease protein (NDP).  Invest Ophthalmol Vis Sci.  2000. 41(4):S30.

 .  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.  N Engl J Med.  2000. 342:381-389.

Hageman G, Mullins R, Russell S, Johnson L, Anderson D.  Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells.  FASEB J.  1999 March. 13(3):477-84.
[Link]

Folk J, Russell S.  Can laser photocoagulation of eyes with high-risk drusen prevent vision loss from age-related macular degeneration? [Guest Editorial].  Ophthalmology.  1999. 106:1241-1242.

Franklin A, Masiero L, Russell S, Kuchemann C, Kohn E.  Carboxyamido-triazole is a potent inhibitor of retinal neovascularization.  Invest Ophthalmol Vis Sci.  1999. 40(4):S705.

Russell S.  Full thickness macular hole.  1999. 

Russell S.  von Hippel-Lindau disease.  1998. 

Franklin A, Dunphy C, Russell S.  Caring for an elderly woman with a hypopyon.  Argus.  1997. 2(8):24-25.

Mullins R, Schneider B, Russell S, Hageman G.  Drusen possess unique glycoconjugate cores.  Invest Ophthalmol Vis Sci.  1997. 38(4):S354.

Russell S, Polk T, Kolder H, Gehrs K, Boldt H, Folk J.  Estimation and measurement of the region of view and induced myopia which results from viewing through intravitreous gas.  Invest Ophthalmol Vis Sci.  1997. 38(4):S669.

Franklin A, Kuehn M, Warner R, Thompsen J, Russell S, Rickman C, Hageman G.  Evaluation of differentially-expressed RPE gene transcripts as candidates for age-related macular degeneration.  Invest Ophthalmol Vis Sci.  1997. 38(4):S352.

Russell S, Hageman G.  Insoluble interphotoreceptor matrix in human vitreous following rhegmatogenous retinal detachment.  Am J Ophthalmol.  1997. 123:386-391.

Polk T, Russell S, Gehrs K, Folk J.  Letter to the Editor Sustained-release ganciclovir implants represent an effective treatment option for many patients with cytomegalovirus (CMV) retinitis.  Retina.  1997. 17:463-464.

Albers J, Brown M, Sima A, Greene D.  Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT).  Muscle Nerve.  1996 February. 19(2):140-6.
[PubMed]

Niesman M, Russell S, Ivester F, Lopez N.  Early monocyte depletion fails to prevent PVR in a rabbit model of the disease.  Invest Ophthalmol Vis Sci.  1996. 37(3):S393.

Russell S, Kincaid M, Hageman G.  Pathological consequences of mechanically-induced posterior vitreous detachment.  Invest Ophthalmol Vis Sci.  1996. 37(3):S497.

Albers J, Brown M, Sima A, Greene D.  Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors.  Neurology.  1996 January. 46(1):85-91.
[PubMed]

Niesman M, Russell S, Hageman G.  Secretion of cytokines and growth factors by cultured human hyalocites and epiretinal membrane explants.  Invest Ophthalmol Vis Sci.  1995. 36(4):S204.

Som A, Gehrs K, Russell S, Bassi C.  Short-wavelength automated perimetry in early age-related macular degeneration.  Invest Ophthalmol Vis Sci.  1995. 36(4):S233.

Russell S, Bassi C, Painter J, Eberhardt C, Taboada J, Peters D.  Amplitude and variability of the laser pattern electroretinographic response from different retinal areas.  Invest Ophthalmol Vis Sci.  1994. 35(4):S1439.

Hageman G, Russell S.  Chondroitinase-mediated disinsertion of the primate vitreous body.  Invest Ophthalmol Vis Sci.  1994. 35(4):S1260.

Sima A, Greene D, Brown M, Hohman T, Hicks D, Graepel G, Bochenek W, Beg M, Gonen B.  Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy.  The Tolrestat Study Group. J Diabetes Complications.  1993 September. 7(3):157-69.
[PubMed]

Santiago J, Snksen P, Boulton A, Macleod A, Beg M, Bochenek W, Graepel G, Gonen B.  Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function.  The Tolrestat Study Group. J Diabetes Complications.  1993 September. 7(3):170-8.
[PubMed]

Albert S, Gomez C, Russell S, Chaitman B, Bernbaum M, Kong B.  Cerebral and ophthalmic artery hemodynamic responses in diabetes mellitus.  Diabetes Care.  1993. 16:476-482.

Crapotta J, Bassi C, Russell S.  Electroretinographic alterations following penetrating wound may result from decreased eyewall resistance.  Invest Ophthalmol Vis Sci.  1993. 4(4):S1118.

Russell S, Crapotta J, Zerbolio Jr D.  Letter to the Editor: Surgical removal of subfoveal neovascularization.  Ophthalmology.  1993. 100:795-797.

Russell S, Crapotta J, Serbolio Jr D.  Letter to the Editor: Surgical removal of subfoveal neovascularization.  Ophthalmology.  1993. 100:795-797.

Russell S, Crapotta J.  Macular epiretinal membranes.  1993. 6(2):239-245.

Russell S, Hageman G.  Chondroitin sulfate-induced generation of epiretinal membranes.  Arch Ophthalmol.  1992. 110:1000-1006.

Hageman G, Russell S.  Enzymatic disinsertion of the primate vitreous body.  Experimental Eye Research.  1992. 55:S216.

Russell S, Hageman G.  Hemorrhagic detachment of the internal limiting membrane following penetrating ocular injury.  Retina.  1992. 12:346-350.

Lazerus H, Russell S, Zahn S, Hageman G.  Histochemical evidence for vitreous hyalocytes as components of pathologic vitreous membranes.  Invest Ophthalmol Vis Sci.  1992. 33(4):S858.

Russell S, Hageman G.  Role of insoluble interphotoreceptor matrix in eliciting vitreous cellular proliferations in the human.  Experimental Eye Research.  1992. 55:S237.

Russell S, Hermsen V.  Acquired retinal macroaneurysms.  Appleton & Lange.  1991. 

Russell S, Hermsen V.  Angiomatosis retinae.  Appleton & Lange.  1991. 

Russell S, Hermsen V.  Choroidal Hemangioma.  Appleton & Lange.  1991. 

Russell S, Shepherd J, Hageman G.  Distribution of glycoconjugates in the human retinal internal limiting membrane.  Invest Ophthalmol Vis Sci.  1991. 32:1986-1995.

Russell S, Hermsen V.  Idiopathic juxtafoveal retinal telangiectasis.  Appleton & Lange.  1991. 

Russell S, Hageman G.  Insoluble interphotoreceptor matrix is present in human vitreous following rhegmatogenous retinal detachment.  Invest Ophthalmol Vis Sci.  1991. 32(4):S878.

Russell S, Hermsen V.  Primary retinal telangiectasis (Coats’ syndrome).  Appleton & Lange.  1991. 

Bennett S, Folk J, Kimura A, Russell S, Stone E, Raphtis B.  Autosomal dominant neovascular inflammatory vitreoretinopathy.  Ophthalmology.  1990. 97:1125-1136.

Blodi C, Russell S, Pulido J, Folk J.  Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser.  Ophthalmology.  1990. 97:791-797.

Russell S, Hageman G.  Intravitreal injection of insoluble interphotoreceptor matrix constituents induces epiretinal membrane formation in monkeys.  Invest Ophthalmol Vis Sci.  1990. 31(4):S197.

Russell S.  Letter to the Editor: Retinal Macroaneurysms treated with yellow dye laser.  Retina.  1990. 10:229.

Russell S.  Book Review: Ophthalmic Lasers.  Am J Ophthalmol.  1989. 108(3):472.

Russell S, Hageman G.  Lectin-based characterization of glycoconjugates in chondroitin sulfate induced epiretinal and intravitreal membranes.  Invest Ophthalmol Vis Sci.  1989. 30(3):S394.

Russell S, Blodi C, Folk J.  Vitrectomy for complicated retinal detachments secondary to branch retinal vein occlusions.  Am J Ophthalmol.  1989. 108:6-9.

Richards D, Russell S, Anderson D.  A method for improved biometry of the anterior chamber with a Scheimpflug technique.  Invest Ophthalmol Vis Sci.  1988 December. 29(12):1826-35.
[Link]

Russell S, Olsen K, Folk J.  Predictors of scleral rupture and the role of vitrectomy in severe blunt ocular trauma.  Am J Ophthalmol.  1988 March 15. 105(3):253-7.
[Link]

Folk J, Russell S.  Appropriate wavelengths for posterior segment laser photocoagulation.  American Academy of Ophthalmology.  1988. VI(Module 7).

Russell S, Folk J.  Branch retinal artery occlusion following dye yellow photocoagulation of an arterial macroaneurysm.  Am J Ophthalmol.  1987. 104:186-187.

Tanenbaum M, Russell S, Richmond P, Gass J.  Calcified cytoid bodies in acquired immunodeficiency syndrome.  Retina.  1987. 7:84-88.

Russell S, Blodi C, Coonan P.  Letter to the Editor: Vitreous amyloidosis.  Ophthalmology.  1987. 94:1672.

Blumenkranz M, Russell S, Robey M, Kott-Blumenkranz R, Penneys N.  Risk factors in age-related maculopathy complicated by choroidal neovascularization.  Ophthalmology.  1986 May. 93(5):552-8.
[Link]

Russell S, Anderson D, Fantes F, Buus D.  Numerical calculation of anterior segment dimensions using the scheimpflug camera.  Invest Ophthalmol Vis Sci.  1985. 26(3):S108.

Blumenkranz M, Russell S, Robey M, Kott-Blumenkranz R, Goldberg R.  Risk factors in age related maculopathy.  Ophthalmology.  1985. 92(8):82.

Klyce S, Russell S.  Water and electrolyte transport in epithelia: Modeling nonlinear systems.  Fed Proc.  1982. 41(4):1266.

Klyce S, Russell S.  The viscous flow theory: An adjunct to the standing gradient hypothesis.  Fed Proc.  1980. 39(3):378.

Klyce S, Russell S.  Cytoplasmic standing gradients could link epithelial Jv to solute transport.  Biophys.  1979. 25:95a.

Klyce S, Russell S.  Numerical solution of coupled transport equations applied to corneal hydration dynamics.  J Physiol.  1979. 292:107-134.

Klyce S, Russell S.  System for monitoring the thickness of transparent layered structures.  Rev Scient Instrum.  1978. 49:1318-1321.

Davis L, Meyer K, Schindler E, Beck J, Rudd D, Grundstad A, Scheetz T, Braun T, Fingert J, Folk J, Russell S, Wassink T, Sheffield V, Stone E.  A Large-Scale Study of Copy Number Variation Implicates Novel Genes Including DMXL1, PAK7 and TULP3 in the Etiology of Primary Open Angle Glaucoma.  Proceedings of the National Academy of Sciences. 

Mahajan V, Russell S, Stone E.  A New Macular Dystrophy with Pigment Spots, Cystic Spaces, and Hemmorrhage. 
[PubMed]

Newmark E, Al-Aswad L, Bidwell A, Choplin N, Duffner L, Ehrenhaus M, Engelstein J, Friedman N, Goldberg D, Goldman D, Horn E, Mitchell K, Moshfeghi A, Oregno-Nania S, Russell S, Shamis D, Shields S, Stern G, Wallshein J.  Certified Ophthalmic Assistant Exam Study Guide. 

Date Last Modified: 06/07/2014 - 21:56:23